ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT Q2 2025
3 juli, 09:00
ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT Q2 2025
Zinzino group revenue increased 56% in Q2, compared with the previous year.
The revenue in June for Zinzino's sales markets increased by 71% and amounted to SEK 255.8 (149.9) million. Faun Pharma's external sales decreased and amounted to SEK 4.8 (6.0) million. Overall, the Group increased revenues by 67% to SEK 260.6 (155.9) million compared with the previous year.
Revenue in Zinzino's sales markets increased by 61% in the second quarter of 2025 compared with the same period last year and amounted to SEK 776.1 (483.3) million. Total revenues in the Group increased by 56% in the second quarter and amounted to SEK 791.0 (507.0) million.
Accumulated revenue for January – June 2025 increased by 58% to SEK 1,514.7 (961.6) million.
Revenues were distributed as follows:
Regions, mSEK | 25-jun | 24-jun | Change | Q2 2025 | Q2 2024 | Change | YTD 2025 | YTD 2024 | Change |
The Nordics | 23,6 | 22,7 | 4% | 76,3 | 73,4 | 4% | 153,6 | 141,5 | 9% |
Central Europe | 80,6 | 41,3 | 95% | 218,1 | 136,3 | 60% | 414,5 | 255,8 | 62% |
East Europe | 25,3 | 32,0 | -21% | 88,7 | 97,8 | -9% | 185,9 | 191,6 | -3% |
South & West Europe | 45,8 | 29,1 | 57% | 137,3 | 89,7 | 53% | 262,2 | 160,3 | 64% |
The Baltics | 8,1 | 6,7 | 21% | 28,0 | 23,7 | 18% | 56,7 | 47,5 | 19% |
North America | 40,8 | 14,3 | 185% | 140,0 | 46,0 | 204% | 252,6 | 81,4 | 210% |
Asia-Pacific | 29,8 | 2,7 | 1004% | 82,3 | 12,9 | 538% | 148,1 | 25,3 | 485% |
Africa | 1,8 | 1,1 | 64% | 5,2 | 3,5 | 50% | 10,2 | 6,9 | 48% |
Zinzino | 255,8 | 149,9 | 71% | 776,1 | 483,3 | 61% | 1 483,8 | 910,3 | 63% |
Faun Pharma | 4,8 | 6,0 | -20% | 14,9 | 23,7 | -37% | 30,9 | 51,3 | -40% |
Zinzino Group | 260,6 | 155,9 | 67% | 791,0 | 507,0 | 56% | 1 514,7 | 961,6 | 58% |
Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines
-Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com
Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com
Pictures for publication free of charge: marketing@zinzino.com
Certified Adviser: DNB Carnegie Investment Bank AB (publ.)
Zinzino is a global direct sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market. Their scientifically proven nutritional supplements are available in more than 100 markets across the world.Zinzino has acquired all assets in the health and wellness companies Zurvita and Xelliss. The company co-owns the Cypriot olive oil producer Cleanthi Alpha-Olenic LTD, and owns theSwiss, biotech skincare brand HANZZ+HEIDII, as well as the Norwegian research and production units BioActive Foods AS and Faun Pharma AS.The company headquarters is in Gothenburg, Sweden with additional offices in Europe, Asia, and Australia.
Ämnen i artikeln
ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT Q2 2025
3 juli, 09:00
ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT Q2 2025
Zinzino group revenue increased 56% in Q2, compared with the previous year.
The revenue in June for Zinzino's sales markets increased by 71% and amounted to SEK 255.8 (149.9) million. Faun Pharma's external sales decreased and amounted to SEK 4.8 (6.0) million. Overall, the Group increased revenues by 67% to SEK 260.6 (155.9) million compared with the previous year.
Revenue in Zinzino's sales markets increased by 61% in the second quarter of 2025 compared with the same period last year and amounted to SEK 776.1 (483.3) million. Total revenues in the Group increased by 56% in the second quarter and amounted to SEK 791.0 (507.0) million.
Accumulated revenue for January – June 2025 increased by 58% to SEK 1,514.7 (961.6) million.
Revenues were distributed as follows:
Regions, mSEK | 25-jun | 24-jun | Change | Q2 2025 | Q2 2024 | Change | YTD 2025 | YTD 2024 | Change |
The Nordics | 23,6 | 22,7 | 4% | 76,3 | 73,4 | 4% | 153,6 | 141,5 | 9% |
Central Europe | 80,6 | 41,3 | 95% | 218,1 | 136,3 | 60% | 414,5 | 255,8 | 62% |
East Europe | 25,3 | 32,0 | -21% | 88,7 | 97,8 | -9% | 185,9 | 191,6 | -3% |
South & West Europe | 45,8 | 29,1 | 57% | 137,3 | 89,7 | 53% | 262,2 | 160,3 | 64% |
The Baltics | 8,1 | 6,7 | 21% | 28,0 | 23,7 | 18% | 56,7 | 47,5 | 19% |
North America | 40,8 | 14,3 | 185% | 140,0 | 46,0 | 204% | 252,6 | 81,4 | 210% |
Asia-Pacific | 29,8 | 2,7 | 1004% | 82,3 | 12,9 | 538% | 148,1 | 25,3 | 485% |
Africa | 1,8 | 1,1 | 64% | 5,2 | 3,5 | 50% | 10,2 | 6,9 | 48% |
Zinzino | 255,8 | 149,9 | 71% | 776,1 | 483,3 | 61% | 1 483,8 | 910,3 | 63% |
Faun Pharma | 4,8 | 6,0 | -20% | 14,9 | 23,7 | -37% | 30,9 | 51,3 | -40% |
Zinzino Group | 260,6 | 155,9 | 67% | 791,0 | 507,0 | 56% | 1 514,7 | 961,6 | 58% |
Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines
-Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com
Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com
Pictures for publication free of charge: marketing@zinzino.com
Certified Adviser: DNB Carnegie Investment Bank AB (publ.)
Zinzino is a global direct sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market. Their scientifically proven nutritional supplements are available in more than 100 markets across the world.Zinzino has acquired all assets in the health and wellness companies Zurvita and Xelliss. The company co-owns the Cypriot olive oil producer Cleanthi Alpha-Olenic LTD, and owns theSwiss, biotech skincare brand HANZZ+HEIDII, as well as the Norwegian research and production units BioActive Foods AS and Faun Pharma AS.The company headquarters is in Gothenburg, Sweden with additional offices in Europe, Asia, and Australia.
Ämnen i artikeln
Börsen idag
-992x558.webp&w=3840&q=75)
Börsen idag
Börsen idag
Mest läst
Börsen idag
Marknadsöversikt
1 DAG %
Senast
1 mån
Privatekonomi med Placeras expert
Affärsvärlden
